Biologics

Regenerative therapeutics company Theradaptive has appointed Frank Vizesi, PhD, as its chief scientific officer. 

Regenerative medicine in spine surgery is an area of the field that still has room for research and growth. 

A man who was paralyzed seven years ago can walk and stand on his own after taking part in a stem cell study at Rochester, Minn.-based Mayo Clinic, ABC News reported April 1.

Cassandra Lee, MD, recently became one of the first surgeons in the U.S. to use the CartiHeal Agili-C cartilage repair implant.

SurGenTec's OsteoFlo hydroputty synthetic bone graft earned 510(k) clearance from the FDA, the medtech company said March 7.

Bone Biologics, a company focused on spine fusion products, recently announced a $2 million public offering.

In February, Zimmer Biomet closed on the acquisition of orthobiologics company Embody for $155 million. Embody focuses on soft tissue healing, and its portfolio includes the Tapestry biointegrative implant for tendon healing and Tapestry RC implant for rotator cuff repair.

Regenerative medicine has been growing in orthopedics, and there's one important element that can push it forward in the field.

Here are four biologics updates Becker's has reported on since Dec. 13:

RTI Surgical signed an agreement to acquire Cook Biotech, according to a Jan. 8 news release.